Lavie Bio Expands Yalos Bio-Inoculant to Winter Wheat Market, Doubling Potential Reach
Portfolio Pulse from Benzinga Newsdesk
Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ:EVGN), is expanding its bio-inoculant product, Yalos™, to the winter wheat market, effectively doubling its potential reach. This expansion follows successful trials and aims to enhance crop productivity and sustainability. Lavie Bio also plans to expand Yalos™ to other key crops like soybean and canola by 2025.
July 02, 2024 | 11:09 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evogene Ltd. (NASDAQ:EVGN) is expanding its subsidiary Lavie Bio's bio-inoculant product, Yalos™, to the winter wheat market, potentially doubling its market reach. This expansion could significantly enhance crop productivity and sustainability, offering substantial market share capture.
The expansion of Yalos™ to the winter wheat market, which is significantly larger than the markets Lavie Bio currently operates in, could lead to increased revenues and market share for Evogene Ltd. The successful trials and potential for enhanced crop productivity further support a positive short-term impact on EVGN's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100